Disc Medicine Files 8-K on Operations and Financials
Ticker: IRON · Form: 8-K · Filed: Feb 27, 2025 · CIK: 1816736
| Field | Detail |
|---|---|
| Company | Disc Medicine, Inc. (IRON) |
| Form Type | 8-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, financials, corporate-actions
TL;DR
Disc Medicine dropped an 8-K detailing its financials and operations - check it for the latest.
AI Summary
Disc Medicine, Inc. filed an 8-K on February 27, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company was formerly known as Gemini Therapeutics, Inc. and FS Development Corp. before changing its name on February 9, 2021, and July 2, 2020, respectively.
Why It Matters
This 8-K filing provides investors with an update on Disc Medicine's operational and financial status, which is crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine 8-K filing providing standard operational and financial information, not indicating any immediate or significant new risks.
Key Players & Entities
- Disc Medicine, Inc. (company) — Registrant
- Gemini Therapeutics, Inc. (company) — Former company name
- FS Development Corp. (company) — Former company name
- February 27, 2025 (date) — Date of report
- February 9, 2021 (date) — Date of name change
- July 2, 2020 (date) — Date of name change
FAQ
What is the primary purpose of this 8-K filing for Disc Medicine, Inc.?
The primary purpose is to report on the company's results of operations and financial condition, and to include financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported was on February 27, 2025.
What were Disc Medicine, Inc.'s previous names?
Disc Medicine, Inc. was formerly known as Gemini Therapeutics, Inc. and FS Development Corp.
On what dates did the company change its name from its former entities?
The company changed its name from Gemini Therapeutics, Inc. on February 9, 2021, and from FS Development Corp. on July 2, 2020.
Where is Disc Medicine, Inc. headquartered?
Disc Medicine, Inc. is headquartered at 321 Arsenal Street, Suite 101, Watertown, MA 02472.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 27, 2025 regarding Disc Medicine, Inc. (IRON).